{"id":"ab-prep","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Injection site pain"},{"rate":"5-15%","effect":"Fatigue"},{"rate":"5-10%","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"AB PREP works by presenting antigens from the SARS-CoV-2 virus to the immune system, eliciting a specific response to neutralize the virus. This approach aims to provide long-term immunity against COVID-19. The exact mechanism of action is not fully understood, but it is believed to involve the activation of T-cells and the production of antibodies.","oneSentence":"AB PREP is a therapeutic vaccine designed to stimulate an immune response against the SARS-CoV-2 virus.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:28:08.391Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"COVID-19 prevention"}]},"trialDetails":[{"nctId":"NCT07085715","phase":"","title":"Pan-Viral Screening and Linkage to Care Among GBMSM and Trans Women in Spain","status":"NOT_YET_RECRUITING","sponsor":"Fundació Institut Germans Trias i Pujol","startDate":"2025-10","conditions":"HIV, Hepatitis B, Hepatitis C","enrollment":500},{"nctId":"NCT06059443","phase":"NA","title":"mLab App Plus: A Randomized Controlled Trial of a Mobile Health (mHealth) Intervention","status":"COMPLETED","sponsor":"Columbia University","startDate":"2023-10-17","conditions":"HIV Infections, Sexually Transmitted Diseases, Viral, Syphilis","enrollment":40},{"nctId":"NCT06461494","phase":"NA","title":"Comparison of Egoscue Versus Pilates Exercises in Patient With Mechanical Low Back Pain","status":"COMPLETED","sponsor":"Riphah International University","startDate":"2024-06-30","conditions":"Low Back Pain","enrollment":34},{"nctId":"NCT04491708","phase":"NA","title":"What is the Metabolic Intensity of Pilates","status":"COMPLETED","sponsor":"Catholic University of Brasília","startDate":"2015-07-01","conditions":"Energy Expenditure","enrollment":18},{"nctId":"NCT00817934","phase":"","title":"Safe, Effective, and More Tolerable 16 Tablets Colon Prep","status":"UNKNOWN","sponsor":"Long Neck Medical Enterprises","startDate":"2009-01","conditions":"Colon Cancer","enrollment":400}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":155,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Reglan, K-Phos neutral, and Dulcolax"],"phase":"phase_2","status":"active","brandName":"AB PREP","genericName":"AB PREP","companyName":"Long Neck Medical Enterprises","companyId":"long-neck-medical-enterprises","modality":"Small molecule","firstApprovalDate":"","aiSummary":"AB PREP is a therapeutic vaccine designed to stimulate an immune response against the SARS-CoV-2 virus. Used for COVID-19 prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}